OFFICIAL PUBLICATION OF

by its subsidiary APPco

Apotex decision a warning bell

Megan Haggan 14/04/2016

Apotex’ decision to pull two of its PBS-listed products should ring an alarm for the health and pharmaceuticals sector, says Belinda Wood, CEO of the Generic and Biosimilar Medicines Association. Yesterday Apotex announced that it will be ceasing supply of two PBS listed prescription products from its portfolio: paracetamol/codeine tablets 500mg/30mg blister pack 20; and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

Apotex decision a warning bell

Previous Queensland pharmacist vaccination now permanent

Next Aussies encouraged to vaccinate and help kids in India

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Queensland pharmacist vaccination now permanent

Next Aussies encouraged to vaccinate and help kids in India

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.